Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience